“
TL;DR
This retrospective cohort study of 475 acute coronary syndrome patients found that a lower hemoglobin-to-creatinine (Hgb/Cr) ratio measured at admission was an independent predictor of long-term mortality.
Medicine · 4 authors, 2 centres
This summary was generated by AI from a single paper. It has not been reviewed by a clinician and is not clinical advice. Verify against the source before acting on it.
This retrospective cohort study of 475 acute coronary syndrome patients found that a lower hemoglobin-to-creatinine (Hgb/Cr) ratio measured at admission was an independent predictor of long-term mortality.
A retrospective cohort study analyzed 475 patients with acute coronary syndrome (ACS) who underwent coronary angiography to evaluate if the admission hemoglobin-to-creatinine (Hgb/Cr) ratio predicts long-term mortality. The mean follow-up was 53.8 months. Non-survivors had a significantly lower Hgb/Cr ratio than survivors. In univariate analysis, the Hgb/Cr ratio was a significant predictor of mortality. After adjusting for age, gender, ejection fraction, hypertension, diabetes, cerebrovascular history, LDL, and medication use, the Hgb/Cr ratio remained an independent predictor. Receiver operating characteristic analysis found an area under the curve of 0.679. Kaplan-Meier analysis showed significantly higher mortality in the low Hgb/Cr group.